These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 24827915)

  • 61. Microneedle-based drug delivery systems for transdermal route.
    Pierre MB; Rossetti FC
    Curr Drug Targets; 2014 Mar; 15(3):281-91. PubMed ID: 24144208
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Perspectives on Transdermal Electroporation.
    Ita K
    Pharmaceutics; 2016 Mar; 8(1):. PubMed ID: 26999191
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Transdermal drug delivery systems: skin perturbation devices.
    Brown MB; Traynor MJ; Martin GP; Akomeah FK
    Methods Mol Biol; 2008; 437():119-39. PubMed ID: 18369965
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Perspectives of Lipid-Based Drug Carrier Systems for Transdermal Delivery.
    Pradhan M; Srivastava S; Singh D; Saraf S; Saraf S; Singh MR
    Crit Rev Ther Drug Carrier Syst; 2018; 35(4):331-367. PubMed ID: 29972681
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Transdermal iontophoretic drug delivery: advances and challenges.
    Ita K
    J Drug Target; 2016; 24(5):386-91. PubMed ID: 26406291
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Topical and Transdermal Delivery of Drug-Loaded Nano/ Microsystems with Application of Physical Enhancement Techniques.
    Borgheti-Cardoso LN; Ângelo T; Gelfuso GM; Lopez RF; Gratieri T
    Curr Drug Targets; 2016; 17(13):1545-59. PubMed ID: 26477464
    [TBL] [Abstract][Full Text] [Related]  

  • 67. An update on the application of physical technologies to enhance intradermal and transdermal drug delivery.
    Herwadkar A; Banga AK
    Ther Deliv; 2012 Mar; 3(3):339-55. PubMed ID: 22833994
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Transdermal iontophoresis. Part I: Basic principles and considerations.
    Nair V; Pillai O; Poduri R; Panchagnula R
    Methods Find Exp Clin Pharmacol; 1999 Mar; 21(2):139-51. PubMed ID: 10327395
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Electroporation as an efficient physical enhancer for skin drug delivery.
    Escobar-Chávez JJ; Bonilla-Martínez D; Villegas-González MA; Revilla-Vázquez AL
    J Clin Pharmacol; 2009 Nov; 49(11):1262-83. PubMed ID: 19717723
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Recent advances in transdermal drug delivery.
    Subedi RK; Oh SY; Chun MK; Choi HK
    Arch Pharm Res; 2010 Mar; 33(3):339-51. PubMed ID: 20361297
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A linear theory of transdermal transport phenomena.
    Edwards DA; Langer R
    J Pharm Sci; 1994 Sep; 83(9):1315-34. PubMed ID: 7830250
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fabrication, Physicochemical Characterization, and Performance Evaluation of Biodegradable Polymeric Microneedle Patch System for Enhanced Transcutaneous Flux of High Molecular Weight Therapeutics.
    Shah V; Choudhury BK
    AAPS PharmSciTech; 2017 Nov; 18(8):2936-2948. PubMed ID: 28432615
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Skin permeabilization for transdermal drug delivery: recent advances and future prospects.
    Schoellhammer CM; Blankschtein D; Langer R
    Expert Opin Drug Deliv; 2014 Mar; 11(3):393-407. PubMed ID: 24392787
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Transdermal drug delivery with a pressure wave.
    Doukas AG; Kollias N
    Adv Drug Deliv Rev; 2004 Mar; 56(5):559-79. PubMed ID: 15019746
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Transdermal delivery of a approximately 13 kDa protein--an in vivo comparison of physical enhancement methods.
    Katikaneni S; Li G; Badkar A; Banga AK
    J Drug Target; 2010 Feb; 18(2):141-7. PubMed ID: 19772395
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synergistic effect of enhancers for transdermal drug delivery.
    Mitragotri S
    Pharm Res; 2000 Nov; 17(11):1354-9. PubMed ID: 11205727
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Permeation enhancer strategies in transdermal drug delivery.
    Marwah H; Garg T; Goyal AK; Rath G
    Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Percutaneous penetration of anticancer agents: Past, present and future.
    Ita K
    Biomed Pharmacother; 2016 Dec; 84():1428-1439. PubMed ID: 27802901
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sonicated transdermal drug transport.
    Joshi A; Raje J
    J Control Release; 2002 Sep; 83(1):13-22. PubMed ID: 12220834
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Formulation and characterisation of dissolving microneedles for the transdermal delivery of therapeutic peptides.
    Dillon C; Hughes H; O'Reilly NJ; McLoughlin P
    Int J Pharm; 2017 Jun; 526(1-2):125-136. PubMed ID: 28461268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.